Anti-HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Anti-HER2 immunoliposomes produced enhanced antitumor efficacy via targeted delivery.
Abstract The identification of tumor-specific cell surface antigens is a critical step toward the development of targeted therapeutics for cancer. The epitope space at the tumor...
h-index: Number of publications with at least h citations each.